The Annals of thoracic surgery · 2026
Effect of donor oxygenation trajectory on lung procurement for transplantation.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Bai Louisa Yunzhu, Yan Yan, Liu Charles R, Yang Zhizhou, Delhi Anjana, Chang Su-Hsin, Farahnak Khashayar, Joseph Karan, Hamilton Christy, Heiden Brendan T, Witt Chad A, Guillamet Rodrigo Vazquez, Byers Derek E, Marklin Gary F, Nicely Bruce, Harmon Michael, Hartwig Matthew G, Nava Ruben G, Patterson G Alexander, Meyers Bryan F, Kozower Benjamin D, Kreisel Daniel, Puri Varun
Аннотация
BACKGROUND: There is a persistent shortage of donor lungs for transplantation. The relationship between donor PaO2 trajectory and lung procurement rate is poorly understood.
METHODS: Demographic and clinical data were abstracted from 4854 brain-dead donors from three US organ procurement organizations between 1/2014 and 6/2020 and from their corresponding lung recipients, if applicable. Donors were first stratified into High versus Low initial PaO2 then by final PaO2, using 300 mmHg as the cutoff. Lung procurement rates and corresponding recipient survival between donor groups were studied using multivariable regression and Cox proportional hazard models, respectively.
RESULTS: Over 75% of donors had Low initial PaO2 (3702/4854). Overall lung procurement rate (LPR, lung donors/all donors) was 32.4% (1574/4854). LPR was greater in the High initial group (40.0% versus 30.1%, p<0.001). In the Low initial group, 1380 (37.3%) donors had High final PaO2, with LPR of 67.9%; frequent bronchoscopy, inotropes, and antibiotics were associated with lung procurement in this group. In the High initial group, 615 (53.4%) donors declined to Low final PaO2; shorter lengths of stay were associated with lung procurement in this group. Among recipients of High final PaO2 donor lungs, overall survival was similar regardless of the initial donor PaO2 (aHR 0.96 [95% CI 0.80-1.15]).
CONCLUSIONS: Low initial PaO2 does not preclude donor lung procurement for transplantation with appropriate donor management. Donor lungs with high initial PaO2 can deteriorate and may not be procured. Interventions targeted at increasing donor oxygenation may improve lung procurement in brain-dead donors without compromising recipient survival.
METHODS: Demographic and clinical data were abstracted from 4854 brain-dead donors from three US organ procurement organizations between 1/2014 and 6/2020 and from their corresponding lung recipients, if applicable. Donors were first stratified into High versus Low initial PaO2 then by final PaO2, using 300 mmHg as the cutoff. Lung procurement rates and corresponding recipient survival between donor groups were studied using multivariable regression and Cox proportional hazard models, respectively.
RESULTS: Over 75% of donors had Low initial PaO2 (3702/4854). Overall lung procurement rate (LPR, lung donors/all donors) was 32.4% (1574/4854). LPR was greater in the High initial group (40.0% versus 30.1%, p<0.001). In the Low initial group, 1380 (37.3%) donors had High final PaO2, with LPR of 67.9%; frequent bronchoscopy, inotropes, and antibiotics were associated with lung procurement in this group. In the High initial group, 615 (53.4%) donors declined to Low final PaO2; shorter lengths of stay were associated with lung procurement in this group. Among recipients of High final PaO2 donor lungs, overall survival was similar regardless of the initial donor PaO2 (aHR 0.96 [95% CI 0.80-1.15]).
CONCLUSIONS: Low initial PaO2 does not preclude donor lung procurement for transplantation with appropriate donor management. Donor lungs with high initial PaO2 can deteriorate and may not be procured. Interventions targeted at increasing donor oxygenation may improve lung procurement in brain-dead donors without compromising recipient survival.